Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Belluco

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 23, 2023
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective seriesSilvia Ministrini, Maria Bencivenga, Federica Filippini, et al.
The AAPS Journal|June 16, 2010
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technologyClaudia Fredolini, Francesco Meani, Alessandra Luchini, et al.
International Journal of Colorectal Disease|June 30, 2022
The impact of anastomotic leak on long-term oncological outcomes after low anterior resection for mid-low rectal cancer: extended follow-up of a randomised controlled trialQuoc Riccardo Bao, Gianluca Pellino, Gaya Spolverato, et al.
Frontiers in Oncology|March 8, 2021
Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal CancerRoberto Innocente, Federico Navarria, Roberto Petri, et al.
Breast Cancer Research : BCR|December 3, 2020
Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detectionClaudia Fredolini, Khyatiben V Pathak, Luisa Paris, et al.
Annals of Surgical Oncology|December 2, 2021
Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh TrialFrancesco Marchegiani, Valeria Palatucci, Giulia Capelli, et al.
International Journal of Surgery (London, England)|December 17, 2025
Quality of life and functional outcomes after rectal sparing approaches following neoadjuvant therapy for rectal cancer: a prospective cohort multicentre studyTeresa Gavaruzzi, Paola Del Bianco, Laura Gavagna, et al.
Plos One|November 6, 2009
Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patientsBih-Rong Wei, Shelley B Hoover, Mark M Ross, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancerVincenzo Valentini, Maria Antonietta Gambacorta, Francesco Cellini, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 27, 2025
Comparing local excision with watch and wait for the management of rectal cancer patients responding to neoadjuvant chemoradiotherapy: Composite endpoint analysis using the win ratioGiulia Capelli, Giulia Lorenzoni, Maria Vittoria Chiaruttini, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 23, 2023
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective seriesSilvia Ministrini, Maria Bencivenga, Federica Filippini, et al.
The AAPS Journal|June 16, 2010
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technologyClaudia Fredolini, Francesco Meani, Alessandra Luchini, et al.
International Journal of Colorectal Disease|June 30, 2022
The impact of anastomotic leak on long-term oncological outcomes after low anterior resection for mid-low rectal cancer: extended follow-up of a randomised controlled trialQuoc Riccardo Bao, Gianluca Pellino, Gaya Spolverato, et al.
Frontiers in Oncology|March 8, 2021
Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal CancerRoberto Innocente, Federico Navarria, Roberto Petri, et al.
Breast Cancer Research : BCR|December 3, 2020
Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detectionClaudia Fredolini, Khyatiben V Pathak, Luisa Paris, et al.
Annals of Surgical Oncology|December 2, 2021
Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh TrialFrancesco Marchegiani, Valeria Palatucci, Giulia Capelli, et al.
International Journal of Surgery (London, England)|December 17, 2025
Quality of life and functional outcomes after rectal sparing approaches following neoadjuvant therapy for rectal cancer: a prospective cohort multicentre studyTeresa Gavaruzzi, Paola Del Bianco, Laura Gavagna, et al.
Plos One|November 6, 2009
Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patientsBih-Rong Wei, Shelley B Hoover, Mark M Ross, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancerVincenzo Valentini, Maria Antonietta Gambacorta, Francesco Cellini, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 27, 2025
Comparing local excision with watch and wait for the management of rectal cancer patients responding to neoadjuvant chemoradiotherapy: Composite endpoint analysis using the win ratioGiulia Capelli, Giulia Lorenzoni, Maria Vittoria Chiaruttini, et al.
Pageof 7